Tert-butyl N-[(3R)-3-[(1S)-1-(4-bromophenyl)-2-oxo-2-pyrazol-1-ylethyl]-1-methyl-2-oxoindol-3-yl]carbamate
C25H25BrN4O4 — CID 102338851
Data last refreshed: (MolForge compound catalog, from PubChem)
About Tert-butyl N-[(3R)-3-[(1S)-1-(4-bromophenyl)-2-oxo-2-pyrazol-1-ylethyl]-1-methyl-2-oxoindol-3-yl]carbamate
Tert-butyl N-[(3R)-3-[(1S)-1-(4-bromophenyl)-2-oxo-2-pyrazol-1-ylethyl]-1-methyl-2-oxoindol-3-yl]carbamate (PubChem CID 102338851) has the molecular formula C25H25BrN4O4 and a molecular weight of 525.40 g/mol. Its IUPAC name is tert-butyl N-[(3R)-3-[(1S)-1-(4-bromophenyl)-2-oxo-2-pyrazol-1-ylethyl]-1-methyl-2-oxoindol-3-yl]carbamate.
Molecular Properties
| Compound Name | Tert-butyl N-[(3R)-3-[(1S)-1-(4-bromophenyl)-2-oxo-2-pyrazol-1-ylethyl]-1-methyl-2-oxoindol-3-yl]carbamate |
|---|---|
| PubChem CID | 102338851 |
| Molecular Formula | C25H25BrN4O4 |
| Molecular Weight | 525.40 g/mol |
| Exact Mass | 524.11 |
| IUPAC Name | tert-butyl N-[(3R)-3-[(1S)-1-(4-bromophenyl)-2-oxo-2-pyrazol-1-ylethyl]-1-methyl-2-oxoindol-3-yl]carbamate |
| SMILES | CN1C(=O)[C@@](NC(=O)OC(C)(C)C)([C@@H](C(=O)n2cccn2)c2ccc(Br)cc2)c2ccccc21 |
| InChI | InChI=1S/C25H25BrN4O4/c1-24(2,3)34-23(33)28-25(18-8-5-6-9-19(18)29(4)22(25)32)20(16-10-12-17(26)13-11-16)21(31)30-15-7-14-27-30/h5-15,20H,1-4H3,(H,28,33)/t20-,25+/m1/s1 |
| InChIKey | AGHPNLKRPUEJCD-NLFFAJNJSA-N |
| XLogP | 4.47 |
| TPSA | 93.53 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 34 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 525.40 |
| LogP ≤ 5 | 4.47 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 102338851 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.